109386-71-2

Basic information

• Product Name: METHYL 4-[4-BENZYL-N-(2-METHOXYCARBONYLETHYL)]AMINOBUTYRATE
• Synonyms: METHYL 4-[4-BENZYL-N-(2-METHOXYCARBONYLETHYL)]AMINOBUTYRATE;4-[(3-Methoxy-3-oxopropyl)(phenylMethyl)aMino]butanoic Acid Methyl Ester
• CAS NO: 109386-71-2
• Molecular Formula: C₁₆H₂₃NO₄
• Molecular Weight: 293.36
• Product Categories: Miscellaneous Reagents
• Mol File: 109386-71-2.mol

Chemical Properties

• Appearance: /
• Solubility: Chloroform, DMF, DMSO
• CAS DataBase Reference: METHYL 4-[4-BENZYL-N-(2-METHOXYCARBONYLETHYL)]AMINOBUTYRATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 4-[4-BENZYL-N-(2-METHOXYCARBONYLETHYL)]AMINOBUTYRATE(109386-71-2)
• EPA Substance Registry System: METHYL 4-[4-BENZYL-N-(2-METHOXYCARBONYLETHYL)]AMINOBUTYRATE(109386-71-2)

Safety Data

• Hazardous Substances Data: 109386-71-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
METHYL 4-[4-BENZYL-N-(2-METHOXYCARBONYLETHYL)]AMINOBUTYRATE is used as an intermediate compound for the synthesis of antidepressant drugs, specifically dibenzothiepinol and thienobenzothiepinol ether. Its chemical structure allows for the development of novel antidepressant medications that can potentially offer improved efficacy and reduced side effects compared to existing treatments.
The compound's role in the synthesis process is crucial, as it contributes to the formation of the final antidepressant drug. Its chemical properties, such as being a clear, colorless oil, make it suitable for use in the pharmaceutical industry, where purity and stability are essential factors in drug development.

Upstream product

• 14273-85-9 methyl 4-iodobutanoate 
• 23574-01-8 3-benzylamino-propionic acid methyl ester 
• 4897-84-1 Methyl 4-bromobutyrate 

Downstream Products

• 1208-76-0 1-benzyl-1,2,3,5,6,7-hexahydroazepine-4-one hydrochloride 
• 109386-80-3 1-benzyl-1-azoniabicyclo<3.2.0>heptane chloride 
• 109386-79-0 1-benzyl-4-chloroperhydroazepine hydrochloride 
• 109386-81-4 1-benzyl-4-chloroperhydroazepine 
• 109162-29-0 1-benzyl-4-hydroxyhexahydro-1H-azepine 

Relevant articles and documents

COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS

Compositions and methods for the treatment of viral infections include conjugates containing inhibitors of viral neuraminidase (e.g., zanamivir, peramivir, or analogs thereof) linked to an Fc monomer, an Fc domain, and Fc-binding peptide, an albumin protein, or albumin-binding peptide. In particular, conjugates can be used in the treatment of viral infections (e.g., influenza viral infections).

HETEROCYCLIC ETHERS DERIVED FROM 6,11-DIHYDRODIBENZOTHIEPIN-11-OLS AND 4,9-DIHYDROTHIENO-2-BENZOTHIEPIN-4-OL; A NEW SERIES OF POTENTIAL ANTIDEPRESSANTS AND ANTIHISTAMINE AGENTS

Reactions of 11-chloro-6,11-dihydrodibenzothiepin and methanesulfonates of 6,11-dihydrodibenzothiepin-11-ol (I), its 2-methyl derivative II and 4,9-dihydrothieno-2-benzothiepin-4-ol (III) with 1-methylpiperidin-4-ol, 1-methylperhydroazepin-4-ol (XIX), and tropine gave the ethers V-X.Their methanesulfonates were pharmacologically tested and showed antireserpine, anticataleptic, and antihistamine activities of various degree.The most active compounds were the ethers V and VI.